DAVID HOFMAN: Open Payments
NPI 1760190326 · NEW LENOX, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,518 in 67 payments from 17 companies in 2025. Trend: 2023 $866 · 2024 $1,120 · 2025 $1,518
Food & beverage: $1,518
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $256 |
| Novartis Pharmaceuticals Corporation | 13 | $215 |
| E.R. Squibb & Sons, L.L.C. | 12 | $161 |
| Novo Nordisk Inc | 5 | $149 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $138 |
| Kestra Medical Technology Services, Inc. | 4 | $90 |
| AstraZeneca Pharmaceuticals LP | 4 | $85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $83 |
| Amgen Inc. | 4 | $70 |
| PFIZER INC. | 3 | $62 |
Products named: Rapiblyk, LEQVIO, LifeVest, CAMZYOS, Wegovy, Assure WCD, ELIQUIS, WAINUA.
Industry payments across IL — which companies pay providers there.
